(Total Views: 73)
Posted On: 11/17/2025 9:50:08 AM
Post# of 85880
$CVM CEL-SCI’s Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia: Allows for Patient Access and Reimbursement/Sale Upon Granting of the Designation Which Takes Approximately 60 Days Based on SFDA Timeline
https://x.com/momostockspick/status/1990432062206353659
(0)
(0)
